• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟与帕金森病:尼古丁会影响α-突触核蛋白的纤维化吗?

Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation?

作者信息

Hong Dong-Pyo, Fink Anthony L, Uversky Vladimir N

机构信息

Department of Chemistry and Biochemistry, University of California at Santa Cruz, Santa Cruz, California 95064, USA.

出版信息

Biochim Biophys Acta. 2009 Feb;1794(2):282-90. doi: 10.1016/j.bbapap.2008.09.026. Epub 2008 Oct 25.

DOI:10.1016/j.bbapap.2008.09.026
PMID:19013262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2647853/
Abstract

alpha-synuclein is a small presynaptic protein (14,460 D) that is abundantly distributed in the brain. Although, its function is unknown, the aggregated form of alpha-synuclein is a pathological hallmark of several neurodegenerative diseases, including Parkinson's disease (PD). Epidemiological studies have shown that smoking can lessen the incidence of Parkinson's disease, indicating that smoke may contain chemicals that are neuro-protective. The fibrillation of alpha-synuclein was studied in relation to five different compounds found in cigarette smoke: anabasine, cotinine, hydroquinone, nicotine and nornicotine. Thioflavin T assays, gel electrophoresis, size exclusion chromatography-high performance liquid chromatography (SEC-HPLC) and atomic force microscopy (AFM) were utilized to monitor the rate of alpha-synuclein fibrillation and the inhibitory effects of the cigarette smoke components. We show that nicotine and hydroquinone inhibit alpha-synuclein fibril formation in a concentration-dependent manner, with nicotine being more effective. The SEC-HPLC data show that nicotine and hydroquinone stabilize soluble oligomers. The morphology of the oligomers stabilized by nicotine was evaluated by AFM, which showed the presence of three stable oligomers with an average height of 16 nm, 10 nm and 4 nm. Comparable results were obtained for the effect of the cigarette smoke components on the A53T mutant fibrillation. These results show that nicotine and hydroquinone inhibit alpha-synuclein fibrillation and stabilize soluble oligomeric forms. This information can be used to understand the molecular mechanism of the nicotine and hydroquinone action to develop therapeutic solutions for PD.

摘要

α-突触核蛋白是一种小的突触前蛋白(14,460道尔顿),在大脑中广泛分布。尽管其功能尚不清楚,但α-突触核蛋白的聚集形式是包括帕金森病(PD)在内的几种神经退行性疾病的病理标志。流行病学研究表明,吸烟可降低帕金森病的发病率,这表明烟雾中可能含有具有神经保护作用的化学物质。研究了α-突触核蛋白的纤维化与香烟烟雾中发现的五种不同化合物的关系:新烟草碱、可替宁、对苯二酚、尼古丁和去甲烟碱。利用硫黄素T检测、凝胶电泳、尺寸排阻色谱-高效液相色谱(SEC-HPLC)和原子力显微镜(AFM)来监测α-突触核蛋白的纤维化速率以及香烟烟雾成分的抑制作用。我们发现尼古丁和对苯二酚以浓度依赖的方式抑制α-突触核蛋白纤维的形成,其中尼古丁更有效。SEC-HPLC数据表明尼古丁和对苯二酚可稳定可溶性寡聚体。通过AFM评估了由尼古丁稳定的寡聚体的形态,结果显示存在三种稳定的寡聚体,平均高度分别为16纳米、10纳米和4纳米。对于香烟烟雾成分对A53T突变体纤维化的影响也获得了类似的结果。这些结果表明尼古丁和对苯二酚抑制α-突触核蛋白纤维化并稳定可溶性寡聚体形式。这些信息可用于理解尼古丁和对苯二酚作用的分子机制,以开发针对帕金森病的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/624d3a13bdda/nihms92160f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/25a6159eb78a/nihms92160f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/c122b31d6489/nihms92160f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/b7d18d7448cc/nihms92160f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/438d3d7bd6f9/nihms92160f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/996ab7bca45c/nihms92160f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/20b69ffa7da2/nihms92160f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/bd01b4c12298/nihms92160f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/eb2176ba4cde/nihms92160f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/f549f6bee9cf/nihms92160f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/a0489480ceba/nihms92160f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/7d66fb61ef8a/nihms92160f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/624d3a13bdda/nihms92160f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/25a6159eb78a/nihms92160f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/c122b31d6489/nihms92160f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/b7d18d7448cc/nihms92160f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/438d3d7bd6f9/nihms92160f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/996ab7bca45c/nihms92160f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/20b69ffa7da2/nihms92160f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/bd01b4c12298/nihms92160f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/eb2176ba4cde/nihms92160f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/f549f6bee9cf/nihms92160f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/a0489480ceba/nihms92160f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/7d66fb61ef8a/nihms92160f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41b5/2647853/624d3a13bdda/nihms92160f12.jpg

相似文献

1
Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation?吸烟与帕金森病:尼古丁会影响α-突触核蛋白的纤维化吗?
Biochim Biophys Acta. 2009 Feb;1794(2):282-90. doi: 10.1016/j.bbapap.2008.09.026. Epub 2008 Oct 25.
2
Nicotine slows down oligomerisation of α-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease.尼古丁减缓α-突触核蛋白寡聚化并改善帕金森病酵母模型的细胞毒性。
Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1454-1463. doi: 10.1016/j.bbadis.2017.02.002. Epub 2017 Feb 4.
3
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.由α-突触核蛋白以及与帕金森病相关的两种突变形式在体外形成的原纤维是典型的淀粉样蛋白。
Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r.
4
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.与早发性帕金森病相关的α-突触核蛋白突变的共同特性是加速寡聚化而非纤维化:对发病机制和治疗的启示。
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):571-6. doi: 10.1073/pnas.97.2.571.
5
Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation.对绵羊 α-突触核蛋白的分析为减少纤维形成提供了分子策略。
Biochim Biophys Acta Proteins Proteom. 2017 Mar;1865(3):261-273. doi: 10.1016/j.bbapap.2016.12.008. Epub 2016 Dec 19.
6
Mechanisms of protein oligomerization: inhibitor of functional amyloids templates α-synuclein fibrillation.蛋白质寡聚化的机制:功能性淀粉样纤维模板抑制剂α-突触核蛋白纤维形成。
J Am Chem Soc. 2012 Feb 22;134(7):3439-44. doi: 10.1021/ja209829m. Epub 2012 Feb 9.
7
Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.定义导致小鼠帕金森病表型的α-突触核蛋白种类。
J Biol Chem. 2019 Jul 5;294(27):10392-10406. doi: 10.1074/jbc.RA119.007743. Epub 2019 May 29.
8
Characterization of the non-fibrillar α-synuclein oligomers.非纤维状α-突触核蛋白寡聚体的特性分析。
Protein Pept Lett. 2011 Mar;18(3):230-40. doi: 10.2174/092986611794578332.
9
DnaK/DnaJ/GrpE of Hsp70 system have differing effects on alpha-synuclein fibrillation involved in Parkinson's disease.Hsp70 系统的 DnaK/DnaJ/GrpE 对帕金森病中涉及的α-突触核蛋白纤维形成有不同的影响。
Int J Biol Macromol. 2010 Mar 1;46(2):275-9. doi: 10.1016/j.ijbiomac.2009.12.017. Epub 2010 Jan 7.
10
Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein.由黄酮类化合物黄芩素稳定的α-突触核蛋白寡聚体的结构特征
J Mol Biol. 2008 Oct 31;383(1):214-23. doi: 10.1016/j.jmb.2008.08.039. Epub 2008 Aug 23.

引用本文的文献

1
Repurposing the memory-promoting meclofenoxate hydrochloride as a treatment for Parkinson's disease through integrative multi-omics analysis.通过整合多组学分析将具有促进记忆作用的盐酸甲氯芬酯重新用于帕金森病治疗。
NPJ Parkinsons Dis. 2025 Jun 13;11(1):167. doi: 10.1038/s41531-025-01027-7.
2
Exploring Risk and Protective Factors in Parkinson's Disease.探索帕金森病的风险因素和保护因素。
Cells. 2025 May 14;14(10):710. doi: 10.3390/cells14100710.
3
Nicotine Ameliorates α-Synuclein Preformed Fibril-Induced Behavioral Deficits and Pathological Features in Mice.

本文引用的文献

1
Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein.由黄酮类化合物黄芩素稳定的α-突触核蛋白寡聚体的结构特征
J Mol Biol. 2008 Oct 31;383(1):214-23. doi: 10.1016/j.jmb.2008.08.039. Epub 2008 Aug 23.
2
Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.α-突触核蛋白聚集的神经病理学、生物化学及生物物理学
J Neurochem. 2007 Oct;103(1):17-37. doi: 10.1111/j.1471-4159.2007.04764.x. Epub 2007 Jul 10.
3
Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases.
尼古丁改善小鼠中α-突触核蛋白预形成纤维诱导的行为缺陷和病理特征。
Appl Biochem Biotechnol. 2025 May;197(5):3026-3047. doi: 10.1007/s12010-024-05086-z. Epub 2025 Jan 16.
4
The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease.天然产物在帕金森病治疗中抑制α-突触核蛋白异常聚集的潜力。
Front Pharmacol. 2024 Oct 23;15:1468850. doi: 10.3389/fphar.2024.1468850. eCollection 2024.
5
Influence of Cigarette Aerosol in Alpha-Synuclein Oligomerization and Cell Viability in SH-SY5Y: Implications for Parkinson's Disease.香烟气溶胶对 SH-SY5Y 细胞中α-突触核蛋白寡聚化和细胞活力的影响:对帕金森病的启示。
ACS Chem Neurosci. 2024 Apr 3;15(7):1484-1500. doi: 10.1021/acschemneuro.3c00771. Epub 2024 Mar 14.
6
Autophagy and UPS pathway contribute to nicotine-induced protection effect in Parkinson's disease.自噬和 UPS 途径共同促成尼古丁诱导的帕金森病保护作用。
Exp Brain Res. 2024 Apr;242(4):971-986. doi: 10.1007/s00221-023-06765-9. Epub 2024 Mar 2.
7
Nicotine-mediated effects in neuronal and mouse models of synucleinopathy.尼古丁在突触核蛋白病的神经元和小鼠模型中的介导作用。
Front Neurosci. 2023 Aug 31;17:1239009. doi: 10.3389/fnins.2023.1239009. eCollection 2023.
8
The controversial effect of smoking and nicotine in SARS-CoV-2 infection.吸烟和尼古丁在新冠病毒感染中的争议性影响。
Allergy Asthma Clin Immunol. 2023 Jun 1;19(1):49. doi: 10.1186/s13223-023-00797-0.
9
Association between smoking and all-cause mortality in Parkinson's disease.帕金森病中吸烟与全因死亡率之间的关联。
NPJ Parkinsons Dis. 2023 Apr 11;9(1):59. doi: 10.1038/s41531-023-00486-0.
10
The protective role of cigarette smoking against Parkinson's disease via moderation of the interaction between iron deposition in the nigrostriatal pathway and clinical symptoms.吸烟通过调节黑质纹状体通路铁沉积与临床症状之间的相互作用对帕金森病起到保护作用。
Quant Imaging Med Surg. 2022 Jul;12(7):3603-3624. doi: 10.21037/qims-21-1090.
尼古丁在体外的抗纤维原生成和纤维不稳定活性:对路易体病预防和治疗的意义。
Exp Neurol. 2007 Jun;205(2):414-24. doi: 10.1016/j.expneurol.2007.03.002. Epub 2007 Mar 7.
4
Study on the binding of Thioflavin T to beta-sheet-rich and non-beta-sheet cavities.硫黄素T与富含β-折叠和非β-折叠腔的结合研究。
J Struct Biol. 2007 Jun;158(3):358-69. doi: 10.1016/j.jsb.2006.12.010. Epub 2006 Dec 31.
5
Advances in the treatment of Parkinson's disease.帕金森病治疗的进展
Prog Neurobiol. 2007 Jan;81(1):29-44. doi: 10.1016/j.pneurobio.2006.11.009. Epub 2007 Jan 25.
6
A century-old debate on protein aggregation and neurodegeneration enters the clinic.一场关于蛋白质聚集与神经退行性变的百年争论进入了临床阶段。
Nature. 2006 Oct 19;443(7113):774-9. doi: 10.1038/nature05290.
7
The aggregation and fibrillation of alpha-synuclein.α-突触核蛋白的聚集和纤维化
Acc Chem Res. 2006 Sep;39(9):628-34. doi: 10.1021/ar050073t.
8
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?淀粉样疾病是由模仿细菌成孔毒素的蛋白质聚集体引起的吗?
Q Rev Biophys. 2006 May;39(2):167-201. doi: 10.1017/S0033583506004422. Epub 2006 Sep 18.
9
Smoking, nicotine and Parkinson's disease.吸烟、尼古丁与帕金森病。
Trends Neurosci. 2004 Sep;27(9):561-8. doi: 10.1016/j.tins.2004.06.008.
10
Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease.α-突触核蛋白、多巴胺与生物膜之间的相互作用:理解帕金森病神经退行性变的一些线索
J Mol Neurosci. 2004;23(1-2):23-34. doi: 10.1385/jmn:23:1-2:023.